FULC
FULC
NASDAQ · Pharmaceuticals

Fulcrum Therapeutics Inc

$6.77
-0.27 (-3.84%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 2 13%
Sell 1 6%
Price Target
Analyst Price Target +741.7% upside
Low Target $37.54
Average Target $56.98
High Target $60.88
Current Price $6.77
Current
$6.77
Target
$56.98
$37.54 $56.98 avg $60.88
Scenario Analysis
Bear Case
$37.54
454.5%
Low target
Base Case
$56.98
+741.7%
Avg target
Bull Case
$60.88
+799.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$15.74
-57.0% from high
52-Week Low
$2.32
+192.4% from low
Target vs 52W High
$56.98
+262.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%